IS4168A - Samsetningar til gjafar um endaþarm sem innihaldaondansetrón á fríu basa formi þess - Google Patents

Samsetningar til gjafar um endaþarm sem innihaldaondansetrón á fríu basa formi þess

Info

Publication number
IS4168A
IS4168A IS4168A IS4168A IS4168A IS 4168 A IS4168 A IS 4168A IS 4168 A IS4168 A IS 4168A IS 4168 A IS4168 A IS 4168A IS 4168 A IS4168 A IS 4168A
Authority
IS
Iceland
Prior art keywords
administration
compositions
free base
base form
rectum
Prior art date
Application number
IS4168A
Other languages
English (en)
Other versions
IS1868B (is
Inventor
Thielemans Isabelle
Richard Isabelle
Original Assignee
Laboratoires Glaxo S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Glaxo S.A. filed Critical Laboratoires Glaxo S.A.
Publication of IS4168A publication Critical patent/IS4168A/is
Publication of IS1868B publication Critical patent/IS1868B/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IS4168A 1993-05-25 1994-05-19 Samsetningar til gjafar um endaþarm sem innihaldaondansetrón á fríu basa formi þess IS1868B (is)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939310756A GB9310756D0 (en) 1993-05-25 1993-05-25 Compositions

Publications (2)

Publication Number Publication Date
IS4168A true IS4168A (is) 1994-11-26
IS1868B IS1868B (is) 2003-05-02

Family

ID=10736089

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4168A IS1868B (is) 1993-05-25 1994-05-19 Samsetningar til gjafar um endaþarm sem innihaldaondansetrón á fríu basa formi þess

Country Status (38)

Country Link
US (1) US5741806A (is)
EP (1) EP0700290B1 (is)
JP (1) JP2965703B2 (is)
KR (1) KR100297212B1 (is)
CN (1) CN1106194C (is)
AP (1) AP544A (is)
AT (1) ATE183643T1 (is)
AU (1) AU680918B2 (is)
BE (1) BE1007158A3 (is)
BR (1) BR1100046A (is)
CA (1) CA2162919C (is)
CO (1) CO4230094A1 (is)
CY (1) CY2411B1 (is)
CZ (1) CZ291041B6 (is)
DE (1) DE69420266T2 (is)
DK (1) DK0700290T3 (is)
EC (1) ECSP941088A (is)
ES (1) ES2136198T3 (is)
FR (1) FR2705569B1 (is)
GB (2) GB9310756D0 (is)
GR (1) GR3031669T3 (is)
HR (2) HRP940315B1 (is)
HU (1) HU227121B1 (is)
IE (1) IE80632B1 (is)
IL (1) IL109749A (is)
IS (1) IS1868B (is)
IT (1) IT1272990B (is)
MY (1) MY111445A (is)
NO (1) NO306448B1 (is)
NZ (1) NZ267415A (is)
PE (1) PE13395A1 (is)
PL (1) PL175578B1 (is)
RU (1) RU2132684C1 (is)
SA (1) SA94150003B1 (is)
SG (1) SG48119A1 (is)
SI (1) SI0700290T1 (is)
WO (1) WO1994027599A1 (is)
ZA (1) ZA943593B (is)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060067986A (ko) * 1998-06-15 2006-06-20 세프라코 아이엔시. 무호흡증, 대식증, 다른 질환을 치료하기 위한 광학적으로순수한 (+)-노르씨사프라이드의 용도
EP1464333A3 (en) * 1998-06-15 2004-12-15 Sepracor Inc. Use of optically pure (-) norcisapride in the treatment of apnea, bulimia, and other disorders
EP1468685A3 (en) * 1998-06-15 2004-12-15 Sepracor Inc. Use of optically pure (+)-norcisapride for treating apnea, bulimia and other disorders
TR200003707T2 (tr) * 1998-06-15 2001-06-21 Sepracor Inc. Apne , bulimi ve başka bozuklukların tedavi edilmesi için optik açıdan saf (-) norsisapridin kullanımı
US6362202B1 (en) 1999-03-02 2002-03-26 Sepracor Inc. Methods and compositions using (−) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists
US6353005B1 (en) 1999-03-02 2002-03-05 Sepracor, Inc. Method and compositions using (+) norcisapride in combination with proton pump inhibitors or H2 receptor antagonist
JP5048201B2 (ja) * 2000-08-04 2012-10-17 ディーエムアイ バイオサイエンシズ インコーポレイテッド ジケトピペラジン類の使用方法とジケトピペラジン類を含む組成物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695578A (en) * 1984-01-25 1987-09-22 Glaxo Group Limited 1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances
PH22672A (en) * 1984-01-25 1988-11-14 Glaxo Group Ltd Imidazolylmethyltetrahydrocarbazolone derivatives, composition and method of use thereof
GB8516083D0 (en) * 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds
GB8627909D0 (en) * 1986-11-21 1986-12-31 Glaxo Group Ltd Medicaments
GB8816187D0 (en) * 1988-07-07 1988-08-10 Glaxo Group Ltd Medicaments
GB8914804D0 (en) * 1989-06-28 1989-08-16 Glaxo Group Ltd Process
US5166145A (en) * 1990-09-10 1992-11-24 Alza Corporation Antiemetic therapy

Also Published As

Publication number Publication date
EP0700290A1 (en) 1996-03-13
CN1106194C (zh) 2003-04-23
GR3031669T3 (en) 2000-02-29
IE940420A1 (en) 1994-11-30
CN1124454A (zh) 1996-06-12
NO306448B1 (no) 1999-11-08
GB9310756D0 (en) 1993-07-14
FR2705569A1 (fr) 1994-12-02
DK0700290T3 (da) 2000-03-13
IL109749A0 (en) 1994-08-26
ES2136198T3 (es) 1999-11-16
GB9409835D0 (en) 1994-07-06
IE80632B1 (en) 1998-10-21
HRP940315B1 (en) 2000-12-31
KR100297212B1 (ko) 2001-10-24
HUT74867A (en) 1997-02-28
IT1272990B (it) 1997-07-01
MY111445A (en) 2000-05-31
WO1994027599A1 (en) 1994-12-08
CA2162919A1 (en) 1994-12-08
CO4230094A1 (es) 1995-10-19
AP9400643A0 (en) 1994-07-31
DE69420266T2 (de) 1999-12-09
BE1007158A3 (fr) 1995-04-11
IL109749A (en) 1999-03-12
JPH08510457A (ja) 1996-11-05
CZ308595A3 (en) 1996-06-12
ATE183643T1 (de) 1999-09-15
ITRM940322A1 (it) 1995-11-24
FR2705569B1 (fr) 1995-11-10
ITRM940322A0 (it) 1994-05-24
HU227121B1 (en) 2010-07-28
RU2132684C1 (ru) 1999-07-10
HRP940315A2 (en) 1996-08-31
CY2411B1 (en) 2004-11-12
AU680918B2 (en) 1997-08-14
SG48119A1 (en) 1998-04-17
IS1868B (is) 2003-05-02
CA2162919C (en) 1999-07-20
SA94150003B1 (ar) 2005-04-11
GB2279008A (en) 1994-12-21
JP2965703B2 (ja) 1999-10-18
SI0700290T1 (en) 1999-12-31
HRP970315A2 (en) 1999-04-30
US5741806A (en) 1998-04-21
BR1100046A (pt) 1999-11-23
ZA943593B (en) 1995-02-13
PL311721A1 (en) 1996-03-04
NO954783L (no) 1995-11-24
AP544A (en) 1996-10-11
NZ267415A (en) 1997-10-24
PE13395A1 (es) 1995-05-25
DE69420266D1 (de) 1999-09-30
NO954783D0 (no) 1995-11-24
PL175578B1 (pl) 1999-01-29
ECSP941088A (es) 1994-11-16
AU6970994A (en) 1994-12-20
EP0700290B1 (en) 1999-08-25
HU9503375D0 (en) 1996-01-29
GB2279008B (en) 1997-06-18
CZ291041B6 (cs) 2002-12-11

Similar Documents

Publication Publication Date Title
DE69423626D1 (de) Gaserzeugende rückstandsfreie azidfreie zusammensetzung
PT589843E (pt) Composicoes farmaceuticas contendo ciclosporinas
FI925615A0 (fi) Stabiliserade farmaceutiska kompositioner, som innehaoller en hmg-coa-reduktas-inhibitorfoerening
FI955812L (fi) Siirrettävän tiedon koostumuksen säilyttäminen tukiaseman vaihdon yhteydessä
FI922364A7 (fi) Farmaseuttiset koostumukset
UY24316A1 (es) Composiciones refrescantes
NO921777D0 (no) Fremgangsmaate for fremstilling av isoparaffiner
IT8920486A0 (it) Composizioni farmaceutiche.
NO305832B1 (no) FremgangsmÕte for fremstilling av metanol
NO900934D0 (no) Fremgangsmaate for fremstilling av 4-substituerte piperaziner.
IL85312A0 (en) Improving the stability of pharmaceutical compositions
BR9007732A (pt) Composicao desodorante
IT8820386A0 (it) Composizioni farmaceutiche orosolubili contenti acetilcisteina.
IT8920068A0 (it) Composizione deodorante.
DK348089A (da) Halvlederkomposition
ITRM920349A0 (it) Composizioni farmaceutiche contenenti il-6
FI940219A7 (fi) Nestemäisiä deodoranttikoostumuksia
BR9506389A (pt) Composto á base desilicio aplicação da composição 2-oxobenzil- oxi-dimetilsilano composição terapêutica composição dietética e composição cosmética resultantes da aplicação
FI883673A7 (fi) Farmaceutiska kompositioner.
IS1868B (is) Samsetningar til gjafar um endaþarm sem innihaldaondansetrón á fríu basa formi þess
NO893344L (no) Anvendelse av kopolymerer som tilsetningsmiddel for sementmoertelblandinger.
BR9307800A (pt) ComposiçÕes anticárie
IT1270905B (it) Composizioni farmaceutiche contenenti n-acetilcarnosina per il trattamento della cataratta
BR9103183A (pt) Composicao desodorante
IT1290797B1 (it) Composizioni farmaceutiche stabilizzate